Gastroenterology and Hepatology Department, University Hospital Miguel Servet, Zaragoza, Spain.
Instituto Aragonés Investigación Sanitaria, Zaragoza, Spain.
Nutr Clin Pract. 2021 Oct;36(5):1003-1010. doi: 10.1002/ncp.10640. Epub 2021 Apr 5.
The use of nutrition-screening tools in cirrhotic patients is not systematized. Recently, specific tools have been proposed for patients with cirrhosis, but their diagnostic capabilities have been scarcely studied.
This was a prospective study that includes outpatients with liver cirrhosis undergoing follow-up in the hepatology consultations of a tertiary-care university hospital. A trained gastroenterologist applied the screening tools: Liver Disease Universal Screening Tool (LDUST), Royal Free Hospital-Nutrition Prioritizing Tool (RFH-NPT), and Mini Nutritional Assessment-Short Form (MNA-SF). Subsequently, the diagnosis of malnutrition was made according to Global Leadership Initiative for Malnutrition (GLIM) criteria by an endocrinologist, who was blind to the results of the screening tools.
Sixty-three patients (38.1% women, mean age 63.1 ± 9.9 years) with cirrhosis (60.3% Child-Pugh A, 34.9% Child-Pugh B, and 4.8% Child-Pugh C) were evaluated. The prevalence of malnutrition was 38.1% (15.9% moderate, 22.2% severe). Advanced stages of cirrhosis were associated with a higher prevalence of malnutrition (P = .021). MNA-SF was the most accurate screening tool, being superior to RFH-NPT and LDUST. It presented better sensitivity than RFH-NPT (88% [0.68-0.97] vs 67% [0.45-0.84], P = .031) and better specificity than both LDUST (97% [0.87-0.99] vs 62% [0.45-0.77], P < .001) and RFH-NPT (97% [0.87-0.99] vs 82% [0.67-0.93], P = .016).
According to the GLIM criteria, malnutrition affected 38.1% of patients with cirrhosis, being severe in 22% of the patients. MNA-SF is the most accurate screening test, superior even to tools specifically designed for cirrhotic patients (LDUST).
目前尚未对肝硬化患者的营养筛查工具进行系统使用。最近,已针对肝硬化患者提出了一些特定的工具,但尚未对其诊断能力进行深入研究。
这是一项前瞻性研究,纳入了在一家三级保健大学医院的肝脏病学咨询中接受随访的肝硬化门诊患者。一名经过培训的胃肠病学家应用了以下筛查工具:肝病普遍筛查工具(LDUST)、皇家自由医院营养优先筛查工具(RFH-NPT)和迷你营养评估-简短表格(MNA-SF)。随后,内分泌学家根据全球营养不良领导倡议(GLIM)标准对营养不良进行诊断,该内分泌学家对筛查工具的结果不了解。
共评估了 63 例肝硬化患者(38.1%为女性,平均年龄 63.1±9.9 岁)(60.3%为 Child-Pugh A 级,34.9%为 Child-Pugh B 级,4.8%为 Child-Pugh C 级)。营养不良的患病率为 38.1%(15.9%为中度,22.2%为重度)。肝硬化晚期与营养不良患病率较高相关(P=0.021)。MNA-SF 是最准确的筛查工具,优于 RFH-NPT 和 LDUST。其敏感性优于 RFH-NPT(88%[0.68-0.97]比 67%[0.45-0.84],P=0.031),特异性优于 LDUST(97%[0.87-0.99]比 62%[0.45-0.77],P<0.001)和 RFH-NPT(97%[0.87-0.99]比 82%[0.67-0.93],P=0.016)。
根据 GLIM 标准,38.1%的肝硬化患者存在营养不良,其中 22%的患者为重度营养不良。MNA-SF 是最准确的筛查试验,甚至优于专为肝硬化患者设计的工具(LDUST)。